Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Apr 2001):
Free Full Text!
See links below

Insulin lispro and regular insulin in pregnancy.

Full Abstract

We assessed the safety of insulin lispro in gestational, type 1 and type 2 diabetes mellitus, analysing 635 pregnancies over a period of 7 years. We also evaluated patient satisfaction, sending an internationally-accepted anonymous diabetes treatment satisfaction questionnaire to 22 patients (three type 1, 19 gestational diabetes) who received regular and lispro insulin in successive pregnancies. The success rate of pregnancies in women with gestational diabetes managed with diet alone (n=325) was 99.3%. All 213 pregnancies in women with gestational diabetes requiring insulin were successful. There was no difference in maternal or fetal outcomes whether patients used regular insulin (n=138) or insulin lispro (n=75), but pre-delivery HbA1c was lower with insulin lispro (p<0.05). Pregnancy loss in patients with pre-gestational diabetes (89 pregnancies in type 1 and eight in type 2 diabetes) was 18.6% for insulin and 3.7% for insulin lispro (p=0.10). The incidences of congenital anomalies with regular insulin were 7.9% and 15.8% in gestational and pre-gestational diabetes, respectively; the figures for insulin lispro were 6.6% (p=0.79) and 3.8% ( p=0.16), respectively. Nineteen of the 22 surveyed patients completed the questionnaire. Satisfaction was higher with insulin lispro (26.3+/-2.3 vs. 18+/-8.9, p=0.0005). We found no increase in adverse outcome using lispro insulin in diabetic pregnancies, in either gestational or pre-gestational diabetes. Patient satisfaction favoured insulin lispro. Several patients with type 1 diabetes who used regular insulin during pregnancy, chose lispro after delivery, but all who used lispro in pregnancy preferred to continue.

 

Author information

Author/s: Bhattacharyya, A (A); Brown, S (S); Hughes, S (S); Vice, P A (PA);

Affiliation: Department of Medicine, Division of Diabetes, Preston Acute Hospital NHS Trust, Preston, UK. arpandev(-atsign-)aol.com

Journal and publication information

Publication Type: Comparative Study; Journal Article

Journal: QJM : monthly journal of the Association of Physicians (QJM), published in England. (Language: eng)

Reference: 2001-May; vol 94 (issue 5) : pp 255-60

Dates: Created 2001/05/15; Completed 2001/06/21; Revised 2007/11/15;

PMID: 11353099, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Hemoglobin A, Glycosylated (0) ; Hypoglycemic Agents (0) ; Insulin (11061-68-0) ; insulin LISPRO (133107-64-9)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

10/30/1991
3/19/2008
Higher Relevance Score (21)
Lower Relevance Score (18)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index